dihydroergotamine has been researched along with flunarizine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arteaga Manjón-Cabez, R; Herranz Fernández, J; Lastra Martínez, L | 1 |
| Soyka, D | 1 |
| Bousser, MG; Massiou, H | 1 |
| Gerber, WD; Langohr, HD; Mangold, R; Reinecke, M | 1 |
| Heidrich, H | 1 |
| Cano, A; Roquer, J | 1 |
| Titus, F | 1 |
| Henry, P | 1 |
1 review(s) available for dihydroergotamine and flunarizine
| Article | Year |
|---|---|
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents | 1990 |
3 trial(s) available for dihydroergotamine and flunarizine
| Article | Year |
|---|---|
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents | 1990 |
[Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders | 1988 |
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
5 other study(ies) available for dihydroergotamine and flunarizine
| Article | Year |
|---|---|
[Beta receptor blockers in migraine].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Cinnarizine; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Hypotension; Migraine Disorders; Time Factors | 1985 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1986 |
[Ambulatory care of chronic headache secondary to abuse of ergot preparations].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dihydroergotamine; Ergot Alkaloids; Female; Flunarizine; Headache; Humans; Male; Middle Aged; Naproxen; Prospective Studies; Substance-Related Disorders; Time Factors; Vasodilator Agents | 1996 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1997 |
[Migraine: a disease, not a symptom].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents | 2002 |